Masimo's claims falter as Apple defends smartwatch designs in court
Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...
Apple Continues Working to Get Blood Oxygen Sensing Back in U.S. Apple Watches as Next Masimo Trial Begins
Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple ...
9to5Mac17d
Neither Apple nor Masimo could admit what the $250 case was really about
It was really about the O2 sensor patent infringement case Masimo brought against Apple. In theory, that’s a completely unrelated case. In practice, not so much. If you need a quick recap ...
Hosted on MSN10mon
Masimo CEO claims the Apple Watch Blood Oxygen sensors are inaccurate — and that users will be "better off" without them
As always, the man from Masimo has strong words. Apple has replied. The firm claims that the blood oxygen sensor is accurate, and that, in essence, Kiani isn’t telling the truth. The difference ...
Masimo: EPS Exceeds Forecasts, Risks Up
Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.
TMCnet19h
Masimo to Present in the Jefferies London Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the ...
Apple wins patent lawsuit (and $250) from Masimo — but it won’t affect Apple Watch’s MIA blood oxygen feature
In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...
Buy Rating Recommended for Masimo: Strong EPS Performance and Strategic Growth Prospects
Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...